Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

174.90
-0.7500-0.43%
Pre-market: 178.153.25+1.86%08:56 EDT
Volume:1.52M
Turnover:268.18M
Market Cap:23.47B
PE:-49.92
High:179.39
Open:175.00
Low:173.82
Close:175.65
52wk High:179.39
52wk Low:55.38
Shares:134.20M
Float Shares:129.78M
Volume Ratio:1.06
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-105.31
PE(LYR):-52.68

Loading ...

Guardant Health Chief Legal Officer John G. Saia sells USD 1.26 million in common shares

Reuters
·
May 29

Guardant Health to present 38 abstracts at ASCO 2026 meeting

TIPRANKS
·
May 28

Guardant Health (GH) Gets a Buy from Piper Sandler

TIPRANKS
·
May 28

Guardant Health set to present 38 abstracts at ASCO annual meeting

Reuters
·
May 28

Canaccord Genuity Reaffirms Their Buy Rating on Guardant Health (GH)

TIPRANKS
·
May 28

Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)

TIPRANKS
·
May 28

Movement Alert|Guardant Health Rises 5.87% in Pre-Market Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines

Market Focus
·
May 28

Guardant Health Is Maintained at Buy by BTIG

Dow Jones
·
May 28

Guardant Health price target raised to $160 from $155 at BTIG

TIPRANKS
·
May 28

Movement Alert|Guardant Health Rises 5.26% in Regular Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines

Market Focus
·
May 28

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid S&P 500, Nasdaq Rally, Middle East Peace Optimism

MT Newswires Live
·
May 27

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live
·
May 27

Guardant Health Says Shield Blood Test Included in American Cancer Society Guidelines

MT Newswires Live
·
May 27

Guardant Health FDA Win Sparks Interest In Liquid Biopsy Valuation Gap

Simply Wall St.
·
May 27

Guardant Health Chief Commercial Officer Chris Freeman disposes of 24,406 common shares worth $2.9 million

Reuters
·
May 27

Guardant Health Is Maintained at Buy by BTIG

Dow Jones
·
May 26

Guardant Health Inc : Btig Raises Target Price to $155 From $145

THOMSON REUTERS
·
May 26

Assessing Guardant Health (GH) Valuation After A Strong Share Price Run

Simply Wall St.
·
May 24

Guardant Health Chief Legal Officer John G. Saia sells USD 2.11 million common shares

Reuters
·
May 23

Guardant Health Co-CEO AmirAli Talasaz disposes of shares worth $22.18 million

Reuters
·
May 23